News and Insights

Insights Library

The Numerof 2024 US Health Insurance Outlook


As our Numerof 2024 U.S. Health Insurance Outlook infographic illustrates, the story for health insurance continues to be about dramatically changing roles and relationships. Payers will continue to engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in…

The Numerof 2024 Global Medical Device Outlook


As our 2024 Global Medical Device Outlook infographic illustrates, medical device manufacturers face a broad array of market challenges in 2024. That said, the global outlook for the industry is positive, with growth projections ranging from 5-7% CAGR over the next five years. Background trends offer both opportunities and threats,…

The Numerof 2024 US Healthcare Delivery Outlook


With the May 2023 expiration of the public health emergency (PHE) in the U.S., the page was turned on the pandemic. But the aftereffects remain. Staffing shortages are endemic, right up to and including physicians; staff dissatisfaction is at historic levels, leading to large scale labor disputes and nurses seeking…

The Numerof 2024 Global Pharma Outlook


As our Numerof 2024 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about responding to growing pressure on price from government payers, and to the increasing complexity and power of a consolidating yet financially pressed healthcare delivery market in the U.S. Across the globe, the…

New Report Highlights Pharma Commercial Model Requires an Urgent Overhaul


The pharmaceutical industry is in the midst of profound transformation. Downward economic pressures, a tightening federal regulatory environment and changes in competition and market expectations are upending the traditional pharmaceutical commercial model. As these pressures intensify, the need for a new model becomes increasingly evident. While many manufacturers are adapting,…